BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 646547)

  • 1. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
    Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT
    Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Afterload reduction in the treatment of cardiac failure.
    Mason DT
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
    Malacco E; Limonta A; Milanesi A; Micossi P
    Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
    Kuck KH; Hanrath P; Zehnke A; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1384-8. PubMed ID: 7449634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prazosin in refractory congestive heart failure].
    Timio M; Gentili S; Pede S; Schiaroli M
    Boll Soc Ital Cardiol; 1978; 23(4):768-76. PubMed ID: 757362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
    López-Sendón J; Coma Canella I
    Rev Esp Cardiol; 1981; 34(1):55-61. PubMed ID: 7280350
    [No Abstract]   [Full Text] [Related]  

  • 9. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
    Armstrong PW
    Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD
    J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can prazosin be used in the treatment of refractory heart failure only on the basis of clinical monitoring?
    Nikolić V; Planinc D; Rudar M; Pagon L
    Wien Med Wochenschr; 1987 Jan; 137(1):9-13. PubMed ID: 3590814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapies in the management of congestive heart failure.
    Atkins FL
    J Kans Med Soc; 1980 Feb; 81(2):83-5, 94. PubMed ID: 7351512
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of vasodilator agents in circulatory insufficienty].
    Halawa B
    Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.